EMCDDA home pageEuropean Drug Report 2020
European Drug Report 2020
European Drug Report 2020
COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?
These and other questions are explored in the 2020 European Drug Report, our annual overview of the drug situation in Europe, launched on 22 September.
#GetTheFactsEDR2020
Trends and Developments (English only)
Trends and Developments (88 pages)
The annual Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems, as well as drug policy and responses. It is available in English only.
Key Issues (24 languages)
Key Issues (42 pages)
This report, available in 24 languages, presents a summary of some the main findings of the 'European Drug Report 2020: Trends and Developments', the EMCDDA’s latest analysis of the drug situation in Europe. The issues selected here have been chosen for their policy relevance and general interest.
Statistical Bulletin 2020
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
Launch details
Date: 22 September 2020
Location: online
Press conference panel:
• Ylva Johansson, European Commissioner for Home Affairs
• Laura d’Arrigo, Chair of the EMCDDA Management Board
• Alexis Goosdeel, EMCDDA Director
Time: 10.00 Lisbon / 11.00 CET
Watch live
Participate (journalists only)
Press contacts
From 22–23 September, calls from the media will be dispatched to our frontline team of experts.
Please contact Klaudia Palczak — Tel. (351) 211 21 02 94 or Tel. (351) 211 21 02 00.
Across Europe, staff at the Reitox national focal points will answer country-specific queries.
Languages: The press conference will be in English, with simultaneous interpretation available (ES, DE, FR, PT).
Country-specific interviews: Across Europe, staff at the Reitox national focal points will answer country-specific queries.
EMCDDA press office: press@emcdda.europa.eu
European Commission press contacts:
Adalbert Jahnz — Tel. (32) 229 531 56
Ciara Bottomley — Tel. (32) 229 699 71
Laura Bérard — Tel. (32) 229 557 21
Press material
News
- COVID-19 disruption and a strong drug market bring new threats to health and security in Europe (22.09.2020)
- Save the date: European Drug Report 2020 to be released on 22 September (News release No 6/2020)
Speeches
- Commissioner Johansson’s speech at the virtual launch event of the 2020 European Drug Report (22.09.2020)
- Transcript of speech by EMCDDA Chair of Management Board Laura d’Arrigo (English)
- Transcript of speech by EMCDDA Chair of Management Board Laura d’Arrigo (French)
- Transcript of speech by EMCDDA Director Alexis Goosdeel
Audiovisual material
- Video:European Drug Reporrt 2020: Key Issues
- Video: launch of the European Drug Report 2020: speech by Commissioner Ylva Johansson
- Video: launch of the European Drug Report 2020: presentation by EMCDDA Director Alexis Goosdeel
- Video: launch of the European Drug Report 2020: speech by Chair of the EMCDDA Management Board Laura d’Arrigo
- European Drug Report 2020 promotional video
- Alexis Goosdeel quote: news release No 7/2020 (MP3)
National launches
- Cyprus: details available soon